The SEC disagrees with you and all of the false claims on ARYC, ARRAYIT...
The Commission temporarily suspended trading in the securities of ARYC because of questions regarding the accuracy and adequacy of publicly-available information concerning ARYC, including: (1) its financial condition and its operations, if any, in light of the absence of any public disclosures by the company since 2015, and (2) information in the marketplace since at least March 2, 2020, claiming that ARYC developed an approved COVID-19 blood test.